Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease
- PMID: 22152074
- DOI: 10.1111/j.1475-097X.2011.01046.x
Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease
Abstract
Background: Patients with chronic obstructive pulmonary disease (COPD) show different spirometric response patterns to bronchodilator, such that some patients show improvement principally in expiratory flow (forced expiratory volume in 1 s; FEV(1)), whereas others respond by improvement of lung volume (forced vital capacity; FVC). The mechanisms of these different response patterns to bronchodilator remain unclear. We investigated the associations between bronchodilator responsiveness and quantitative computed tomography (CT) indices in patients with COPD.
Methods: Data on a total of 101 patients with stable COPD were retrospectively analysed. Volume and flow responses to bronchodilator were assessed by FVC and FEV(1) changes before and after inhalation of salbutamol (400 μg). Volumetric CT was performed to quantify emphysema, air trapping and large airway thickness. Emphysema was assessed by the volume fraction of the lung under -950 Hounsfield units (HU; V(950)) at full inspiration and air trapping by the ratio of mean lung density (MLD) at full expiration and inspiration. Airway wall thickness and wall area percentage (WA%; defined as wall area/[wall area + lumen area] × 100), were measured near the origin of right apical and left apico-posterior bronchus.
Results: Among quantitative CT indices, the CT emphysema index (V(950 insp)) showed a significant negative correlation with postbronchodilator FEV(1) change (R = -0·213, P = 0·004), and the CT air-trapping index correlated positively with postbronchodilator FVC change(R = 0·286, P≤0·001). Multiple linear regression analysis showed that CT emphysema index had independent association with postbronchodilator FEV(1) change and CT air-trapping index with postbronchodilator FVC change.
Conclusion: The degrees of emphysema and air trapping may contribute to the different response patterns to bronchodilator in patients with COPD.
© 2011 The Authors. Clinical Physiology and Functional Imaging © 2011 Scandinavian Society of Clinical Physiology and Nuclear Medicine.
Similar articles
-
Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.COPD. 2014 Sep;11(5):503-9. doi: 10.3109/15412555.2014.933952. Epub 2014 Aug 5. COPD. 2014. PMID: 25093696
-
Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography.Lung. 2008 May-Jun;186(3):157-165. doi: 10.1007/s00408-008-9071-0. Epub 2008 Mar 20. Lung. 2008. PMID: 18351420
-
Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease.Eur J Radiol. 2016 Nov;85(11):2144-2151. doi: 10.1016/j.ejrad.2016.09.010. Epub 2016 Sep 13. Eur J Radiol. 2016. PMID: 27776670 Free PMC article. Review.
-
The objective evaluation of obstructive pulmonary diseases with spirometry.Int J Chron Obstruct Pulmon Dis. 2016 Aug 25;11:2009-15. doi: 10.2147/COPD.S113774. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27616884 Free PMC article.
-
[The clinical significance of CT evaluation in chronic obstructive pulmonary disease].Zhonghua Jie He He Hu Xi Za Zhi. 2014 Jan;37(1):45-7. Zhonghua Jie He He Hu Xi Za Zhi. 2014. PMID: 24694974 Review. Chinese. No abstract available.
Cited by
-
Comparison of 2005 and 2021 American Thoracic Society/ European Respiratory Society Criteria for Bronchodilator Response.Thorac Res Pract. 2024 Jul;25(4):168-170. doi: 10.5152/ThoracResPract.2024.23130.. Thorac Res Pract. 2024. PMID: 39128042 Free PMC article.
-
Efficacy and Safety of Roflumilast in Korean Patients with COPD.Yonsei Med J. 2016 Jul;57(4):928-35. doi: 10.3349/ymj.2016.57.4.928. Yonsei Med J. 2016. PMID: 27189287 Free PMC article. Clinical Trial.
-
Study Design and Outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study.Tuberc Respir Dis (Seoul). 2014 Apr;76(4):169-74. doi: 10.4046/trd.2014.76.4.169. Epub 2014 Apr 25. Tuberc Respir Dis (Seoul). 2014. PMID: 24851130 Free PMC article.
-
Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2022 Oct 17;17:2623-2633. doi: 10.2147/COPD.S385733. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36274994 Free PMC article.
-
Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.Drugs. 2014 Sep;74(14):1635-57. doi: 10.1007/s40265-014-0284-7. Drugs. 2014. PMID: 25212789 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical